Tuberculosis biomarkers discovery: developments, needs, and challenges
Year: 2013
Type: review
Source: The Lancet Infectious Diseases
Institutions: Pfizer (United States), University of Medicine and Dentistry of New Jersey, Case Western Reserve University, National Institutes of Health, National Institute of Allergy and Infectious Diseases, École Polytechnique Fédérale de Lausanne, Critical Path Institute, Karolinska University Hospital, Karolinska Institutet, Henry M. Jackson Foundation, University Teaching Hospital, University of Zambia, University College London
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W2064736441
